VGLUT2 in Parkinson's disease: an emerging therapeutic target.

Freyberg Z, Torregrossa MM, Rocha EM

DOI: 10.1080/14728222.2026.2619754
Published: 2026 Feb
Container: Expert opinion on therapeutic targets
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14728222.2026.2619754,
  title = {VGLUT2 in Parkinson's disease: an emerging therapeutic target.},
  author = {Freyberg Z and Torregrossa MM and Rocha EM},
  year = {2026},
  journal = {Expert opinion on therapeutic targets},
  doi = {10.1080/14728222.2026.2619754},
  url = {https://doi.org/10.1080/14728222.2026.2619754}
}

RIS

TY  - JOUR
TI  - VGLUT2 in Parkinson's disease: an emerging therapeutic target.
AU  - Freyberg Z
AU  - Torregrossa MM
AU  - Rocha EM
PY  - 2026
JO  - Expert opinion on therapeutic targets
DO  - 10.1080/14728222.2026.2619754
UR  - https://doi.org/10.1080/14728222.2026.2619754
ER  -

APA

Z, F., MM, T., & EM, R. (2026). VGLUT2 in Parkinson's disease: an emerging therapeutic target.. Expert opinion on therapeutic targets. https://doi.org/10.1080/14728222.2026.2619754

Source records

pubmed · retrieved 2026-09-26T23:58:22.710Z